全球基因组学市场规模、份额、趋势和成长分析报告（2026-2034年）

基因组学市场预计将从 2025 年的 506.7 亿美元成长到 2034 年的 2,077 亿美元，2026 年至 2034 年的复合年增长率为 16.97%。

由于DNA定序技术的进步和定序成本的下降，全球基因组学市场正经历显着扩张。精准医疗、药物研发、农业和生物技术等领域的应用正在拓展市场范围。各国政府和私人机构正大力投资基因组学研究倡议，旨在改善疾病诊断和治疗效果。将基因组学融入临床实践的趋势正持续在全球加速发展。

关键成长要素包括慢性病盛行率上升、对个人化医疗的需求日益增长以及新一代定序技术的快速创新。基因组学在识别遗传疾病和指南标靶治疗方面发挥着至关重要的作用。研究合作的拓展和资金投入的增加也在推动市场成长。基因编辑技术和生物资讯学工具等技术的进步正在进一步提升相关能力。

展望未来，随着数据分析和基于人工智慧的基因组解读准确性的提高，基因组学市场预计将迎来强劲成长。新兴经济体精准医疗计画的拓展可望创造新的机会。伦理和监管框架将持续发展，以支持创新。基因治疗和分子诊断领域的持续突破预计将塑造全球基因组学市场的未来前景。

目录

第一章：引言

第二章执行摘要

第三章 市场变数、趋势与框架

• 市场谱系展望
• 渗透率和成长前景分析
• 价值链分析
• 法律规范
  • 标准与合规性
  • 监管影响分析
• 市场动态
  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场挑战
• 波特五力分析
• PESTLE分析

第四章：全球基因体学市场：依应用与技术划分

• 市场分析、洞察与预测
• 功能基因体学
• 表观基因
• 通路分析
• 生物标记发现

第五章 全球基因体学市场：依技术划分

• 市场分析、洞察与预测
• 顺序
• PCR
• 流式细胞技术
• 微阵列
• 其他的

第六章：全球基因体学市场：依交付成果划分

• 市场分析、洞察与预测
• 产品
• 服务

第七章 全球基因体学市场：依最终用途划分

• 市场分析、洞察与预测
• 临床研究
• 学术机构及政府机构
• 医院和诊所
• 製药和生物技术公司
• 其他的

第八章 全球基因体学市场：按地区划分

• 区域分析
• 北美市场分析、洞察与预测
  • 我们
  • 加拿大
  • 墨西哥
• 欧洲市场分析、洞察与预测
  • 英国
  • 法国
  • 德国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太市场分析、洞察与预测
  • 印度
  • 日本
  • 韩国
  • 澳洲
  • 东南亚
  • 其他亚太国家
• 拉丁美洲市场分析、洞察与预测
  • 巴西
  • 阿根廷
  • 秘鲁
  • 智利
  • 其他拉丁美洲国家
• 中东和非洲市场分析、洞察与预测
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 南非
  • 其他中东和非洲国家

第九章 竞争情势

• 最新趋势
• 公司分类
• 供应链和分销通路合作伙伴（根据现有资讯）
• 市场占有率和市场定位分析（基于现有资讯）
• 供应商情况（基于现有资讯）
• 策略规划

第十章：公司简介

• 主要公司的市占率分析
• 公司简介
  • Agilent Technologies
  • Bio-Rad Laboratories Inc
  • BGI Genomics
  • Color Genomics Inc
  • Danaher Corporation
  • Eppendorf AG
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd
  • GE Healthcare
  • Illumina Inc
  • Myriad Genetics Inc
  • Oxford Nanopore Technologies

The Genomics Market size is expected to reach USD 207.70 Billion in 2034 from USD 50.67 Billion (2025) growing at a CAGR of 16.97% during 2026-2034.

The Global Genomics Market has witnessed significant expansion driven by advancements in DNA sequencing technologies and declining sequencing costs. Applications in precision medicine, drug discovery, agriculture, and biotechnology have broadened the market scope. Governments and private organizations are investing heavily in genomic research initiatives to improve disease diagnosis and treatment outcomes. The integration of genomics into clinical practice continues to accelerate adoption globally.

Key growth drivers include the increasing prevalence of chronic diseases, rising demand for personalized healthcare, and rapid innovation in next-generation sequencing technologies. Genomics plays a crucial role in identifying genetic disorders and guiding targeted therapies. Growing research collaborations and funding support are also strengthening market growth. Technological advancements such as gene editing and bioinformatics tools further enhance capabilities.

Looking forward, the genomics market is expected to grow at a strong pace as data analytics and artificial intelligence improve genomic interpretation. Expansion of precision medicine programs in emerging economies will create new opportunities. Ethical and regulatory frameworks will continue evolving to support innovation. Continued breakthroughs in gene therapy and molecular diagnostics will shape the future of the global genomics market.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application & Technology

• Functional Genomics
• Epigenomics
• Pathway Analysis
• Biomarker Discovery

By Technology

• Sequencing
• PCR
• Flow Cytometry
• Microarrays
• Other Technologies

By Deliverables

• Products
• Services

By End-use

• Clinical Research
• Academic & Government Institutes
• Hospitals & Clinics
• Pharmaceutical & Biotechnology Companies
• Other End Users

COMPANIES PROFILED

• Agilent Technologies, BioRad Laboratories Inc, BGI Genomics, Color Genomics Inc, Danaher Corporation, Eppendorf AG, Eurofins Scientific, F HoffmannLa Roche Ltd, GE Healthcare, Illumina Inc, Myriad Genetics Inc, Oxford Nanopore Technologies

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENOMICS MARKET: BY APPLICATION & TECHNOLOGY 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Application & Technology
• 4.2. Functional Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Epigenomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Pathway Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Biomarker Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENOMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technology
• 5.2. Sequencing Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Flow Cytometry Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Microarrays Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Other Technologies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENOMICS MARKET: BY DELIVERABLES 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Deliverables
• 6.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENOMICS MARKET: BY END-USE 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End-use
• 7.2. Clinical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Academic & Government Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Other End Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENOMICS MARKET: BY REGION 2022-2034(USD MN)

• 8.1. Regional Outlook
• 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.2.1 By Application & Technology
  • 8.2.2 By Technology
  • 8.2.3 By Deliverables
  • 8.2.4 By End-use
  • 8.2.5 United States
  • 8.2.6 Canada
  • 8.2.7 Mexico
• 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.3.1 By Application & Technology
  • 8.3.2 By Technology
  • 8.3.3 By Deliverables
  • 8.3.4 By End-use
  • 8.3.5 United Kingdom
  • 8.3.6 France
  • 8.3.7 Germany
  • 8.3.8 Italy
  • 8.3.9 Russia
  • 8.3.10 Rest Of Europe
• 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.4.1 By Application & Technology
  • 8.4.2 By Technology
  • 8.4.3 By Deliverables
  • 8.4.4 By End-use
  • 8.4.5 India
  • 8.4.6 Japan
  • 8.4.7 South Korea
  • 8.4.8 Australia
  • 8.4.9 South East Asia
  • 8.4.10 Rest Of Asia Pacific
• 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.5.1 By Application & Technology
  • 8.5.2 By Technology
  • 8.5.3 By Deliverables
  • 8.5.4 By End-use
  • 8.5.5 Brazil
  • 8.5.6 Argentina
  • 8.5.7 Peru
  • 8.5.8 Chile
  • 8.5.9 South East Asia
  • 8.5.10 Rest of Latin America
• 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 8.6.1 By Application & Technology
  • 8.6.2 By Technology
  • 8.6.3 By Deliverables
  • 8.6.4 By End-use
  • 8.6.5 Saudi Arabia
  • 8.6.6 UAE
  • 8.6.7 Israel
  • 8.6.8 South Africa
  • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

• 9.1. Recent Developments
• 9.2. Company Categorization
• 9.3. Supply Chain & Channel Partners (based on availability)
• 9.4. Market Share & Positioning Analysis (based on availability)
• 9.5. Vendor Landscape (based on availability)
• 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENOMICS INDUSTRY

• 10.1. Top Companies Market Share Analysis
• 10.2. Company Profiles
  • 10.2.1 Agilent Technologies
  • 10.2.2 Bio-Rad Laboratories Inc
  • 10.2.3 BGI Genomics
  • 10.2.4 Color Genomics Inc
  • 10.2.5 Danaher Corporation
  • 10.2.6 Eppendorf AG
  • 10.2.7 Eurofins Scientific
  • 10.2.8 F. Hoffmann-La Roche Ltd
  • 10.2.9 GE Healthcare
  • 10.2.10 Illumina Inc
  • 10.2.11 Myriad Genetics Inc
  • 10.2.12 Oxford Nanopore Technologies